Cochlear’s strong growth built on R&D investment
Hearing implant manufacturer Cochlear has reported sales revenue up 15 percent to $2.3 billion for FY24, with growth across all business units. Cochlear implant units increased nine percent with strong growth across the developed markets, while services revenue increased 15 percent driven by strong upgrade demand for the Cochlear Nucleus 8 Sound Processor (pictured). Statutory…